medRxiv [Preprint]. 2026 Oct 14:2026.10.13.26365416. doi: 10.64898/2026.10.13.26365416. ABSTRACT BACKGROUND: Biological risk scores provide objective markers of bipolar disorder (BD) liability. Large-scale genome-wide association studies (GWASs) have led to polygenic risk scores (PRSs) that capture genetic liability to BD at the individual level. We lack a comparable large-scale effort to leverage a brain-wide association study (BWAS) to create an imaging risk score (IRS) that captures brain structural liability to BD at the individual-level. Here, we conduct the largest multivariate BWAS of BD and develop a BD IRS. We compare the BD IRS to the PRS and assess their combined […]
Monat: November 2026
Counteracting the overestimation of effect size in mass-univariate brain-wide association studies using cross-validation
Transl Psychiatry. 2026 Nov 4;16(1):612. doi: 10.1038/s41398-026-04529-x. ABSTRACT BACKGROUND: Brain-wide association effects are commonly overestimated in psychiatric neuroimaging research, leading to low replicability and generalizability of findings, and ultimately to poor translation to clinical utility. Cross-validation is currently not standardly used in univariate neuroimaging analyses but could pose a potential counteracting measure for this problem. METHODS: We systematically evaluated the benefit of a cross-validation procedure to expose inflated effect size estimates in mass-univariate voxel-based analysis, using body mass index (BMI) as an example predictor for gray matter. A total of n = 3401 MRI scans from a psychiatric […]
